Processa Pharmaceuticals, Inc. (PCSA) › Net IncomeProcessa Pharmaceuticals, Inc. (PCSA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$2.44M2013: -$3.07M2014: -$4.53M2015: -$3.35M2016: -$1.92M2017: -$1.86M2018: -$3.77M2019: -$3.36M2020: -$14.41M2021: -$11.43M2022: -$27.42M2023: -$11.12M2024: -$11.85M2025: -$13.56M-$13.56M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$13.56M-14.5%2024-$11.85M-6.6%2023-$11.12M+59.4%2022-$27.42M-140.0%2021-$11.43M+20.7%2020-$14.41M-329.3%2019-$3.36M+10.8%2018-$3.77M-102.8%2017-$1.86M+3.2%2016-$1.92M+42.8%2015-$3.35M+25.9%2014-$4.53M-47.5%2013-$3.07M-25.7%2012-$2.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share